[34] Omeprazole, esomeprazole and lansoprazole have a greater potential for drug–drug interactions ... Pantoprazole may be an alternative PPI for consideration. It is a weak inhibitor of CYP2C19 ...

Purpose: Data collected from the Food and Drug Administration (FDA ... make educated decisions regarding the use of droperidol and alternative agents. Summary: A written request was submitted ...

A prominent legal firm in Australia, Shine Lawyers, is exploring a potential class action against makers of common heartburn drugs ... them relating to Nexium and Prilosec (marketed as Losec ...

However, there remains controversy about the overall net clinical benefit of PPIs (omeprazole, rabeprazole ... administrative healthcare databases covering 2009–2020. Ontario drug benefit dispensation ...

The No Pain Act will mandate Medicare insurance coverage for non-opioid pain management, including evidence-based treatments, ...

Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...

By Gina Kolata The blockbuster drug semaglutide, sold as Ozempic for diabetes and ... the pain reduction is greater than ...

Filus’ alternative treatment was a drug called Taxol, which carried the risk of affecting her heart. Her chemotherapy caused hair loss and exhaustion, though Filus did make it to work every day.

A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...